Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Confluence Pharmaceuticals
company
About
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $200K
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$200K
Confluence Pharmaceuticals has raised a total of
$200K
in funding over 2 rounds. Their latest funding was raised on
Apr 12, 2019 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 12, 2019 | Series Unknown | $200K | 1 |
Indiana University Philanthropic Venture Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Confluence Pharmaceuticals is funded by 1 investors.
Indiana University Philanthropic Venture Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Indiana University Philanthropic Venture Fund
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
